Tuesday, September 23, 2025
HomeVenture Capital

Venture Capital

Venture Capital

Klick Health Acquires Peregrine Market Access

Life Sciences Times - 0
Venture Capital

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles

Life Sciences Times - 0
Venture Capital

MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio

Life Sciences Times - 0
Venture Capital

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Life Sciences Times - 0
People on the Move

Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding

Life Sciences Times - 0
Venture Capital

Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing

Life Sciences Times - 0
Venture Capital

Syncell Announces $15 Million Series A Funding

Life Sciences Times - 0
Venture Capital

OpenClinica Acquires BuildClinical

Life Sciences Times - 0
Venture Capital

Tasca Therapeutics Launches with $52 Million Series A Financing

Life Sciences Times - 0
Venture Capital

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Life Sciences Times - 0
Venture Capital

IMPLANET Announces Financing of Around €2 Million

Life Sciences Times - 0
Venture Capital

Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

Life Sciences Times - 0
1...111213...105Page 12 of 105

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv